supported by the National Natural Science Foundation of China(No.22077068);the National Key R&D Program of China(No.2018YFA0507204);the NCC Fund(No.NCC2020FH12);the Natural Science Foundation of Tianjin(No.19JCQNJC05300);the Fundamental Research Funds for the Central Universities。
We have developed a MUC1 antigen-based antitumor vaccine loaded on alum colloid encapsulated insideβ-glucan particles(GP-Al).The constructed vaccine induced strong MUC1 antigen specific Ig G antibody titers and enhan...